Like neuron‐derived MDVs, when astrocyte‐derived MDVs were evaluated in the discovery cohort, the levels of SLC1A2+ and VDAC1+ EVs were significantly decreased in both PD and AD patients (Figure 4B, Figure S1C). The gene discussed is SLC1A2; the disease is Parkinson disease.